Healthcare - Events

Welcome to the Digital Health Envision Summit, where the future of healthcare comes to life! Join us as we bring together Dealmakers, Innovators, Investors, and Decision-makers from the Pharma & Biotech sector to explore the transformative potential of Digital Health therapies and technologies. This Summit is the ultimate platform for discovering new products, unlocking business opportunities, fostering collaboration, and igniting innovation in the industry Immerse yourself in a dynamic environment where Big, Midsize, and Small Pharma & Biotech companies come together to showcase their cutting-edge assets, revolutionary products, ground-breaking technologies, innovative platforms, and game-changing services. Connect with potential Partners and visionary minds who share your passion…

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.   Registration Link: https://pharma-partnering-summit.com/registration.html

Strengthening supplier and internal stakeholder collaborations, innovating in- and outsourcing models, and adopting advanced technologies to streamline development cycle are key to achieving speed-to-patients and capital efficiency – and this is what the 8th R AND D Procurement and Sourcing in Pharma Summit will bring to the table in 2024. Growing with this community over the last 8 years, the summit remains the definitive community for 100+ R AND D Preclinical, Clinical Procurement, Sourcing, Category Management leaders from the likes of Takeda, Eli Lilly, Sarepta, Moderna, Jazz Pharmaceuticals, and Gilead to benchmark best practice, network and seek inspirations. Unlock the benefits of our 3-day summit with dedicated preclinical and clinical tracks. Gain insights from 20+ real-life stori…

Wednesday, May 15, 2024 | 3:00 – 4:00 PM CET  Convincing trial physicians to participate in a clinical trial is an ongoing challenge for sponsors and CROs. For physicians, trials are burdensome on many levels including the time required, administrative hurdles and communications with sponsors and patients. Often, there is little academic merit waiting for them at the end. So it’s not surprising that physicians prefer to put their efforts elsewhere.  Yet, without trials, there is little scientific advancement and less chance to help patients with novel treatments. In this webinar, we are joined by former physician and former CSO of Novartis, Professor Lothar Färber to present exclusive findings from a recent survey conducted by Climedo and Siteworks among 65+ European tr…

Scientex Conferences warmly welcomes all the Participants, Scientists, Doctors, Nurses and Delegates from the globe to join our conference "2nd International Conference on Nursing Care and Patient Safety” on May 16-17, 2024 in Bangkok, Thailand. Nursing Care 2024 is organized around the theme "Analyzing the latest technologies and research in nursing care and patient safety " which will mark a gathering of pioneers and experts from the Medical Industry.

Prioritizing Back Translation from Bedside to Bench and Novel TargetsWith a whopping 7 approvals in the last two years, the field is alive with positive clinical read outs and the drive to get more life changing cell engager therapeutics to patients in indications of huge unmet need. The timely 6th Cell Engager Therapeutics Summit is back once again to meet the needs of the community, focused on reaching new indications by expanding the target space and focusing our content to novel targets as well as continuing the push to focus on the translational challenges of developing cell engager therapies for solid and liquid tumors. Join 100+ of your colleagues from JNJ, Astellas, Amgen, CDR-Life, Regeneron, Immunocore, Crossbow Therapeutics and AstraZeneca in discovery and translational sciences…

Identify Transformative ALS Targets, Seek Translational Biomarkers and Propel More Clinical Approvals Following monumental progress in 2023, the ALS treatment landscape is surging with novel innovation to navigate the complex, multifactorial nature of motor neuron degeneration and develop more truly transformative drugs for sporadic and familial ALS. Capitalizing on rapid pipeline progress and emerging industry investment, the 3rd Annual ALS Drug Development Summit returns to Boston, providing a comprehensive breakdown of the latest motor neuron models, biomarker strategies, approval insights, and novel approaches to target the likes of TDP-43, STMN2, and PIKfyve. Engage in forward-thinking discussions and gain fresh perspectives on the most meaningful endpoints and trial design considerat…

Join this interactive event of like-minded quality-first clinical professionals to explore effective strategies to ensure clinical risk is being mitigated and managed across all stakeholders. Date and Time: Tuesday, 21 May 2024 at 09:00 to Thursday, 23 May 2024 at 17:00

The FDA Modernization Act 2.0 has triggered a new mindset for pharma, with Roche launching the Institute of Human Biology to create better models, and MSD collaborating with Inventia to bioprint 3D in vitro models to screen for neurodegenerative therapeutic candidates. It has never been a more exciting time to bet on 3D tissue models as the future of drug development, as more and more complex in vitro models undergo validation. However, the big question of "when can we have the confidence in standalone 3D models, and how to do it at scale?" persists. Making its timely return to Boston this May, the 9th 3D Tissue Models Summit will enable you and your team to uncover best practices across 23+ real-world applications of complex in vitro models across drug discovery and development. Join us t…

While leading cytokine therapeutic developers are using next-generation cytokine engineering technologies to tackle enduring efficacy and toxicity challenges to take their molecules through the clinic, the field is also looking to novel targets, novel cytokines and an expanded disease focus. As we enter a new era for cytokine therapies, armed with more cutting-edge technologies than ever before and enhanced translational understandings, the field is re-energizing the cytokine space to bring more life-changing drugs to patients. Curating learnings from previous experiences, the 5th Cytokine-Based Drug Development Summit returns as the only industry dedicated cytokine meeting with a disease agnostic approach. The packed 3-day agenda will be addressing topics ranging from oncology to autoimmu…

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.  Rehistration Link:  https://pharma-partnering-summit.com/registration.html

Following the success of the 3rd Annual Psychedelic Therapeutics and Drug Development Conference in 2023, we're thrilled to be hosting the 4th Annual event on May 23-24, 2024 in Boston, Massachusetts. This event has been organized to bring together the world's leading researchers and leaders in academia, industry, the non-profit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid…

As in previous meetings, the 12th FemDIP Symposium will highlight the progress of pregnancy: from pre-pregnancy, trimester by trimester, to labor, delivery and post-partum care, but also will create a Bridge Connecting Medical/Scientific and FemTech Communities. The Symposium's Startup Pavilion will provide an opportunity for startups to connect with key figures in the industry. Date and Time: On Thu, 23 May 2024 14:00 - Sat, 25 May 2024 19:00

The 7th Annual Digi-Tech Pharma & AI conference brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare industry. Meet the decision makers, benchmark and learn from real-life use cases to drive organizational change and to understand the new cutting-edge technologies and practical solutions. In this 7th edition as we explore the novel technologies and developments reforming pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial intelligence, informatics and data science which has redefined the development of new drugs, tackle diseases, improving healthcare and much more.  The enhancements in data management and data i…

The 7th Annual Digi-Tech Pharma & AI conference brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare industry. Meet the decision makers, benchmark and learn from real-life use cases to drive organizational change and to understand the new cutting-edge technologies and practical solutions. In this 7th edition as we explore the novel technologies and developments reforming pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial intelligence, informatics and data science which has redefined the development of new drugs, tackle diseases, improving healthcare and much more.   The enhancements in data management and data…

The Global Clinical Trials Connect 2024 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from the clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management. The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality collab…

The last 3 years continue to see California rising as a competing biotech hub, incubating fast-growing biopharma and becoming a favored satellite site to large pharma in the West Coast. Notable developments include Moderna leasing a new campus in Seattle, Fred Hutchinson Cancer Center opened a $320m campus, and Gilead's new research center underway. However, lingering market volatility simply means lab operations managers within fast-growing biopharma in the West Coast need to be even more adept at business operations, as they play the critical role to the health of R and D pipeline progression and business continuity in 2024. As part of the flagship LAFM community, the premier Lab Operations and Facility Management for Biopharma Summit is here to provide the much-needed support for lab op…

The marcus evans 25th Edition Strategic Project & Portfolio Management for Pharma conference taking place on 3-5 June, 2024 in Barcelona, Spain, will provide a unique opportunity for leading project and portfolio experts to advance their critical decision-making capabilities and further maximise the value of their portfolio from early to late-stage developments. The conference is recognised by senior project & portfolio experts to be one of the most engaging and interactive events for the Pharma industry, bringing both actionable insights through concrete case studies and panels and maximising value of the meeting with unique discussion between expert speakers and attendees. Attending This Premier marcus evans Conference Will Enable You to: Level Up Your Strategic Portfolio Decisi…

In an era marked by remarkable advancements, the inhalation therapy field is rapidly evolving. From Avalyn's $175 million investment in inhaled pulmonary fibrosis trials to Krystal Biotech's FDA clearance for inhaled gene therapy and MIT engineers' work on inhaled nanoparticles, the field is abuzz with new advances and breakthroughs in inhalation delivery. Right now, we explore inhaled therapies as an opportunity to re-purpose modalities to tackle unmet clinical need in diseases like COPD, asthma, IPF, emphysema, and lung cancer, to unlock therapeutic efficacy. Now is the time for the industry to unite and innovate solutions to challenges surrounding particle engineering, stability, and formulation-device compatibility. Immerse yourself in a wealth of knowledge at the 2nd Next Gen Inhalati…